Plus Therapeutics, Inc. - PE Ratio
PSTV
Price:
$4.2
Market Cap:
$10.16M
Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses. A cornerstone of their pipeline is Rhenium-186 NanoLiposome (R-186 NL), a patented radiotherapy specifically engineered to address difficult central nervous system (CNS) cancers, such as recurrent glioblastoma, leptomeningeal metastases, and various brain cancers affecting children. The company has also secured a licensing agreement with NanoTx, Corp. to advance and commercialize NanoTx's treatment for glioblastoma. Founded in 1996 and headquartered in Austin...[Read more]
Industry
Biotechnology
IPO Date
2001-07-11
Stock Exchange
NASDAQ
Ticker
PSTV
PE Ratio
[0.19]
ROE
[-198.48%]
Current Ratio
[2.27]
Dividend Yield
[0%]
Enterprise Value
[7.87M]
Dividend History
The PE Ratio as of June 2026 (TTM) for Plus Therapeutics, Inc. (PSTV) is 0.19
According to Plus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.19. This represents a change of -118.64% compared to the average of -1.02 of the last 4 quarters.
Plus Therapeutics, Inc. (PSTV) Historical PE Ratio (quarterly & annually)
How has PSTV PE Ratio performed in the past?
The mean historical PE Ratio of Plus Therapeutics, Inc. over the last ten years is -0.24. The current 0.19 PE Ratio has changed -8095.79% with respect to the historical average. Over the past ten years (40 quarters), PSTV's PE Ratio was at its highest in in the June 2025 quarter at 0.00. The PE Ratio was at its lowest in in the December 2025 quarter at -3.11.
Average
-0.24
Median
-0.00
Minimum
-1.78
Maximum
-0.00
Plus Therapeutics, Inc. (PSTV) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Plus Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 142.79%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -63.70%
Minimum Annual PE Ratio = -1.78
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.78 | 202.10% |
| 2024 | -0.59 | 142.79% |
| 2023 | -0.00 | -0.69% |
| 2022 | -0.00 | -53.09% |
| 2021 | -0.00 | -18.43% |
| 2020 | -0.00 | 274.22% |
| 2019 | -0.00 | 74.08% |
| 2018 | -0.00 | -61.07% |
| 2017 | -0.00 | -63.70% |
| 2016 | -0.00 | -17.24% |
Plus Therapeutics, Inc. (PSTV) Average PE Ratio
How has PSTV PE Ratio performed in the past?
The current PE Ratio of Plus Therapeutics, Inc. (PSTV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.79
5-year avg
-0.47
10-year avg
-0.24
Plus Therapeutics, Inc. (PSTV) PE Ratio vs. Peers
How is PSTV’s PE Ratio compared to its peers?
Plus Therapeutics, Inc.’s PE Ratio is greater than NextCure, Inc. (-0.11), greater than Boundless Bio, Inc. (-0.57), greater than TAO Synergies Inc. (-0.27), less than Q32 Bio Inc. (4.44), greater than Verrica Pharmaceuticals Inc. (-3.61), greater than AN2 Therapeutics, Inc. (-4.55), greater than Jasper Therapeutics, Inc. (-0.13), greater than Intensity Therapeutics, Inc. (-0.56), greater than Iterum Therapeutics plc (-0.06), greater than Pluri Inc. (-0.70),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.11 | $5.41M | |
| -0.57 | $32.12M | |
| -0.27 | $12.06M | |
| 4.44 | $152.04M | |
| -3.61 | $59.97M | |
| -4.55 | $137.01M | |
| -0.13 | $7.36M | |
| -0.56 | $7.39M | |
| -0.06 | $1.60M | |
| -0.70 | $18.16M |
Build a custom stock screener for Plus Therapeutics, Inc. (PSTV) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Plus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Plus Therapeutics, Inc. (PSTV) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Plus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Plus Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Plus Therapeutics, Inc. (PSTV)?
What is the highest PE Ratio for Plus Therapeutics, Inc. (PSTV)?
What is the 3-year average PE Ratio for Plus Therapeutics, Inc. (PSTV)?
What is the 5-year average PE Ratio for Plus Therapeutics, Inc. (PSTV)?
How does the current PE Ratio for Plus Therapeutics, Inc. (PSTV) compare to its historical average?